Current research on opioid receptor function

Y Feng, X He, Y Yang, D Chao… - Current drug …, 2012 - ingentaconnect.com
The use of opioid analgesics has a long history in clinical settings, although the
comprehensive action of opioid receptors is still less understood. Nonetheless, recent …

[PDF][PDF] Opioids and neuropathic pain

HS Smith - Pain physician, 2012 - painphysicianjournal.com
Opioids are broad spectrum analgesics that may be beneficial to alleviate the intense
perception of algesia in patients suffering with pain. They have been one of the most …

Novel endomorphin analogs are more potent and longer-lasting analgesics in neuropathic, inflammatory, postoperative, and visceral pain relative to morphine

AK Feehan, J Morgenweck, X Zhang… - The Journal of …, 2017 - Elsevier
Activation of the mu-opioid receptor provides the gold standard for pain relief, but most
opioids used clinically have adverse effects that have contributed to an epidemic of …

[HTML][HTML] Focus: Drug Development: Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain

KM Olson, W Lei, A Keresztes, J LaVigne… - The Yale journal of …, 2017 - ncbi.nlm.nih.gov
Opioid drugs like morphine and fentanyl are the gold standard for treating moderate to
severe acute and chronic pain. However, opioid drug use can be limited by serious side …

Multifunctional opioid-derived hybrids in neuropathic pain: Preclinical evidence, ideas and challenges

J Starnowska-Sokół, B Przewłocka - Molecules, 2020 - mdpi.com
When the first-and second-line therapeutics used to treat neuropathic pain (NP) fail to
induce efficient analgesia—which is estimated to relate to more than half of the patients …

Novel pharmacological nonopioid therapies in chronic pain

AD Kaye, EM Cornett, B Hart, S Patil, A Pham… - Current pain and …, 2018 - Springer
Abstract Purpose of Review Opioid use and abuse has led to a worldwide opioid epidemic.
And while opioids are clinically useful when appropriately indicated, they are associated …

The design of multitarget ligands for chronic and neuropathic pain

S Dvoracsko, A Stefanucci, E Novellino… - Future medicinal …, 2015 - Taylor & Francis
Background: Monodrug therapy has been used with success to fight various pathologies.
When one medicine fails, co-administration of two or more drugs at the same time may be …

[HTML][HTML] Novel hybrid compounds, opioid agonist+ melanocortin 4 receptor antagonist, as efficient analgesics in mouse chronic constriction injury model of …

J Starnowska-Sokół, A Piotrowska, J Bogacka… - …, 2020 - Elsevier
When the nerve tissue is injured, endogenous agonist of melanocortin type 4 (MC4)
receptor, α-MSH, exerts tonic pronociceptive action in the central nervous system …

Endogenous opiates and behavior: 2011

RJ Bodnar - Peptides, 2012 - Elsevier
This paper is the thirty-fourth consecutive installment of the annual review of research
concerning the endogenous opioid system. It summarizes papers published during 2011 …

Design, Synthesis and Biological Evaluation of Two Opioid Agonist and Cav2.2 Blocker Multitarget Ligands

A Mollica, R Costante, E Novellino… - Chemical biology & …, 2015 - Wiley Online Library
N‐type voltage‐dependent Ca2+ channels (CaV2. 2) are located at nerve endings in the
central and peripheral nervous systems and are strongly associated with the pathological …